Cargando…
Screening of Fabry disease in patients with end-stage renal disease of unknown etiology: the first Thailand study
We aimed to explore the prevalence of Fabry disease in Thai patients who were diagnosed with end-stage renal disease (ESRD) of an unknown origin. Venous blood samples were collected from ESRD patients for biochemical and molecular studies. Alpha-galactosidase A (α-GAL A) screening was performed from...
Autores principales: | Trachoo, Objoon, Jittorntam, Paisan, Pibalyart, Sarunpong, Kajanachumphol, Saowanee, Suvachittanont, Norasak, Patputthipong, Suthep, Chuengsaman, Piyatida, Nongnuch, Arkom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Department of Journal of Biomedical Research
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5274508/ https://www.ncbi.nlm.nih.gov/pubmed/28808181 http://dx.doi.org/10.7555/JBR.31.20160063 |
Ejemplares similares
-
Anti–SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report
por: Boongird, Sarinya, et al.
Publicado: (2021) -
Short-Term Immunogenicity Profiles and Predictors for Suboptimal Immune Responses in Patients with End-Stage Kidney Disease Immunized with Inactivated SARS-CoV-2 Vaccine
por: Boongird, Sarinya, et al.
Publicado: (2021) -
Durability of Humoral and Cellular Immunity after an Extended Primary Series with Heterologous Inactivated SARS-CoV-2 Prime-Boost and ChAdOx1 nCoV-19 in Dialysis Patients (ICON3)
por: Boongird, Sarinya, et al.
Publicado: (2022) -
Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients
por: Bruminhent, Jackrapong, et al.
Publicado: (2022) -
Chromosome 22q11.2 Deletion Syndrome Presenting as Adult Onset Hypoparathyroidism: Clues to Diagnosis from Dysmorphic Facial Features
por: Korpaisarn, Sira, et al.
Publicado: (2013)